Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sobel

Showing results (141-150 of 538) with videos related to

Pageof 54
Sort By:
The Medical Clinics of North America|June 18, 2011
Antibiotics for gram-positive bacterial infection: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, telavancin, and ceftarolineMichael D Nailor, Jack D Sobel
Obstetrics and Gynecology|June 1, 1986
Recurrent vulvovaginal candidiasis: vaginal epithelial cell susceptibility to Candida albicans adherenceD J Trumbore, J D Sobel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1996
Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virusJ D Sobel, J A Vazquez
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|January 1, 1994
Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolatesM E Lynch, J D Sobel
Infectious Disease Clinics of North America|November 14, 2009
Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancinMichael D Nailor, Jack D Sobel
The New England Journal of Medicine|March 5, 2025
Bacterial Vaginosis - Time to Treat Male PartnersChristina A Muzny, Jack D Sobel
International Journal of Women'S Health|August 15, 2023
Understanding and Preventing Recurring Bacterial Vaginosis: Important Considerations for CliniciansChristina A Muzny, Jack D Sobel
Sexually Transmitted Infections|March 24, 2026
Sexual transmission of vaginal pathogens and male partner treatment: is it time to consider vulvovaginal candidiasis?Jack D Sobel, Christina A Muzny
Contraception, Fertilite, Sexualite (1992)|January 1, 1996
[Immunopathogenesis of recurrent vulvovaginal candidiasis]P L Fidel, J D Sobel
Trends in Microbiology|June 1, 1994
The role of cell-mediated immunity in candidiasisP L Fidel, J D Sobel
Pageof 54

Showing results (141-150 of 538) with videos related to

Sort By:
Pageof 54
The Medical Clinics of North America|June 18, 2011
Antibiotics for gram-positive bacterial infection: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, telavancin, and ceftarolineMichael D Nailor, Jack D Sobel
Obstetrics and Gynecology|June 1, 1986
Recurrent vulvovaginal candidiasis: vaginal epithelial cell susceptibility to Candida albicans adherenceD J Trumbore, J D Sobel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1996
Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virusJ D Sobel, J A Vazquez
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|January 1, 1994
Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolatesM E Lynch, J D Sobel
Infectious Disease Clinics of North America|November 14, 2009
Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancinMichael D Nailor, Jack D Sobel
The New England Journal of Medicine|March 5, 2025
Bacterial Vaginosis - Time to Treat Male PartnersChristina A Muzny, Jack D Sobel
International Journal of Women'S Health|August 15, 2023
Understanding and Preventing Recurring Bacterial Vaginosis: Important Considerations for CliniciansChristina A Muzny, Jack D Sobel
Sexually Transmitted Infections|March 24, 2026
Sexual transmission of vaginal pathogens and male partner treatment: is it time to consider vulvovaginal candidiasis?Jack D Sobel, Christina A Muzny
Contraception, Fertilite, Sexualite (1992)|January 1, 1996
[Immunopathogenesis of recurrent vulvovaginal candidiasis]P L Fidel, J D Sobel
Trends in Microbiology|June 1, 1994
The role of cell-mediated immunity in candidiasisP L Fidel, J D Sobel
Pageof 54